STOCK TITAN

Healthy Extracts Inc Financials

HYEX
Source SEC Filings (10-K/10-Q) Updated Apr 8, 2026 Currency USD FYE April

This page shows Healthy Extracts Inc (HYEX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 53 / 100
Financial Profile 53/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth
100

Healthy Extracts Inc's revenue surged 44.9% year-over-year to $4.5M, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage
99

Healthy Extracts Inc carries a low D/E ratio of 0.16, meaning only $0.16 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
10

Healthy Extracts Inc's current ratio of 0.79 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 10/100, which could limit financial flexibility.

Returns
3

Healthy Extracts Inc generates a -3.7% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 3/100. This is up from -204.9% the prior year.

Piotroski F-Score Weak
3/9

Healthy Extracts Inc passes 3 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed
-0.19x

For every $1 of reported earnings, Healthy Extracts Inc generates $-0.19 in operating cash flow ($166K OCF vs -$881K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$4.5M
YoY+44.9%
5Y CAGR+28.3%
10Y CAGR+44.3%

Healthy Extracts Inc generated $4.5M in revenue in fiscal year 2025. This represents an increase of 44.9% from the prior year.

EBITDA
N/A
Net Income
-$881K
YoY-4.8%

Healthy Extracts Inc reported -$881K in net income in fiscal year 2025. This represents a decrease of 4.8% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$112K
YoY+0.0%
5Y CAGR+13.6%
10Y CAGR+53.6%

Healthy Extracts Inc held $112K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
17M

Healthy Extracts Inc had 17M shares outstanding in fiscal year 2025. This represents an increase of 465.0% from the prior year.

Margins & Returns

Gross Margin
53.7%
YoY-7.7pp
5Y CAGR-10.5pp
10Y CAGR-6.0pp

Healthy Extracts Inc's gross margin was 53.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 7.7 percentage points from the prior year.

Operating Margin
N/A
Net Margin
-19.5%
YoY+7.5pp
5Y CAGR+178.7pp
10Y CAGR+613.0pp

Healthy Extracts Inc's net profit margin was -19.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 7.5 percentage points from the prior year.

Return on Equity
-3.7%
YoY+201.2pp
5Y CAGR+86.6pp
10Y CAGR+558.7pp

Healthy Extracts Inc's ROE was -3.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 201.2 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

HYEX Income Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Revenue $918K-5.2% $969K+4.0% $931K+20.8% $771K+3.5% $745K-18.0% $908K+31.9% $689K+3.0% $669K
Cost of Revenue $471K+25.3% $376K-25.8% $506K+41.9% $357K+150.4% $142K-66.3% $422K+50.6% $280K+171.7% $103K
Gross Profit $447K-24.6% $593K+39.5% $425K+2.6% $414K-31.2% $602K+23.9% $486K+19.0% $408K-27.8% $566K
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $907K+29.9% $698K+30.8% $534K-12.3% $609K+17.8% $517K+3.8% $498K+5.9% $470K-47.0% $888K
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense -$56K-92.0% -$29K+15.3% -$35K+37.1% -$55K-37.6% -$40K+18.0% -$49K-14.5% -$43K-11.5% -$38K
Income Tax N/A N/A $0 N/A N/A N/A $0 N/A
Net Income -$395K-689.1% $67K+116.8% -$399K+10.8% -$447K-226.2% $354K+212.3% $114K+113.2% -$861K-127.5% -$379K
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

HYEX Balance Sheet

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Total Assets $26.2M+949.5% $2.5M+3.5% $2.4M+1.4% $2.4M-3.6% $2.5M-0.7% $2.5M-4.6% $2.6M-1.1% $2.6M
Current Assets $1.7M+10.8% $1.6M+5.4% $1.5M-10.8% $1.7M-4.2% $1.7M-0.9% $1.7M-6.5% $1.9M-1.6% $1.9M
Cash & Equivalents $189K-5.5% $200K+68.8% $119K+6.1% $112K+11.6% $100K-32.3% $148K+69.8% $87K+349.1% $19K
Inventory $967K-12.7% $1.1M-3.1% $1.1M-16.1% $1.4M-5.3% $1.4M+8.9% $1.3M-15.0% $1.6M-4.5% $1.6M
Accounts Receivable $31K+685.5% $4K-94.3% $70K+536.0% $11K-44.3% $20K-78.2% $91K+276.5% $24K-21.0% $30K
Goodwill $193K0.0% $193K0.0% $193K0.0% $193K0.0% $193K0.0% $193K0.0% $193K0.0% $193K
Total Liabilities $2.1M+5.6% $2.0M-14.2% $2.4M+19.5% $2.0M+18.2% $1.7M-20.1% $2.1M-15.0% $2.5M+52.3% $1.6M
Current Liabilities $1.2M+36.2% $862K-63.3% $2.4M+75.5% $1.3M-19.5% $1.7M-20.1% $2.1M-15.0% $2.5M+46.0% $1.7M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $24.1M+4934.2% $478K+689.9% $61K-85.3% $410K-48.9% $803K+100.7% $400K+163.8% $152K-85.2% $1.0M
Retained Earnings -$20.0M-2.0% -$19.6M+0.3% -$19.6M-2.1% -$19.2M-2.4% -$18.8M+1.8% -$19.1M+0.6% -$19.3M-4.7% -$18.4M

HYEX Cash Flow Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Operating Cash Flow -$280K-1725.6% $17K-71.3% $60K+43.3% $42K-19.9% $52K-69.1% $169K+803.0% $19K-66.3% $56K
Capital Expenditures N/A N/A N/A N/A N/A $0 $0 $0
Free Cash Flow N/A N/A N/A N/A N/A $169K+803.0% $19K-66.3% $56K
Investing Cash Flow $0+100.0% -$19K $0 $0 $0 $0 $0 $0
Financing Cash Flow $269K+220.9% $84K+257.4% -$53K-76.0% -$30K+69.8% -$100K+7.4% -$108K-320.1% $49K+159.5% -$83K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

HYEX Financial Ratios

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Gross Margin 48.7%-12.5pp 61.2%+15.6pp 45.6%-8.1pp 53.7%-27.1pp 80.9%+27.4pp 53.5%-5.8pp 59.3%-25.3pp 84.6%
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin -43.1%-50.0pp 6.9%+49.8pp -42.8%+15.2pp -58.0%-105.6pp 47.6%+35.1pp 12.5%+137.5pp -125.0%-68.4pp -56.6%
Return on Equity -1.6%-15.7pp 14.0%+673.2pp -659.2%-550.2pp -109.0%-153.2pp 44.1%+15.8pp 28.4%+596.3pp -567.9%-531.0pp -37.0%
Return on Assets -1.5%-4.2pp 2.7%+19.2pp -16.5%+2.3pp -18.8%-33.2pp 14.4%+9.8pp 4.6%+37.6pp -33.1%-18.7pp -14.4%
Current Ratio 1.47-0.3 1.81+1.2 0.63-0.6 1.24+0.2 1.04+0.2 0.84+0.1 0.76-0.4 1.13
Debt-to-Equity 0.09-4.1 4.22-34.6 38.85+34.1 4.79+2.7 2.07-3.1 5.21-11.0 16.18+14.6 1.57
FCF Margin N/A N/A N/A N/A N/A 18.6%+15.9pp 2.7%-5.6pp 8.3%

Note: The current ratio is below 1.0 (0.79), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

Healthy Extracts Inc (HYEX) reported $4.5M in total revenue for fiscal year 2025. This represents a 44.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Healthy Extracts Inc (HYEX) revenue grew by 44.9% year-over-year, from $3.1M to $4.5M in fiscal year 2025.

No, Healthy Extracts Inc (HYEX) reported a net income of -$881K in fiscal year 2025, with a net profit margin of -19.5%.

Healthy Extracts Inc (HYEX) had a gross margin of 53.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Healthy Extracts Inc (HYEX) had a net profit margin of -19.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Healthy Extracts Inc (HYEX) has a return on equity of -3.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Healthy Extracts Inc (HYEX) generated $166K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Healthy Extracts Inc (HYEX) had $27.8M in total assets as of fiscal year 2025, including both current and long-term assets.

Healthy Extracts Inc (HYEX) had 17M shares outstanding as of fiscal year 2025.

Healthy Extracts Inc (HYEX) had a current ratio of 0.79 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Healthy Extracts Inc (HYEX) had a debt-to-equity ratio of 0.16 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Healthy Extracts Inc (HYEX) had a return on assets of -3.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Healthy Extracts Inc (HYEX) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Healthy Extracts Inc (HYEX) has an earnings quality ratio of -0.19x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Healthy Extracts Inc (HYEX) scores 53 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top